Biotechnology News

November 13, 2012

CHICAGO--(BUSINESS WIRE)--Avery Dennison Corporation (NYSE:AVY) has renamed and repositioned its medical solutions group as Vancive Medical Technologies™.

November 13, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Swedish specialty pharmaceutical company Orexo (STO:ORX) today communicated that its partner Kyowa Hakko Kirin Co., Ltd has submitted a New Drug Application (“NDA”) in Japan for KW-2246 (Abstral...

November 13, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today announced the publication and filing of a circular to shareholders convening an extraordinary general meeting (“EGM”) to be held in the Davenport Hotel, 8/10 Merrion Street Lower,...

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced that management will host a conference call on Tuesday, November 13, 2012 at 8:00 a.m. ET to discuss the restructuring...

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that they and Tekmira Pharmaceuticals Corporation have restructured their relationship with a new licensing agreement and have resolved all litigation...

November 12, 2012

WALTHAM, Mass. & SHANGHAI--(BUSINESS WIRE)--PerkinElmer Acquires China-based Infectious Disease Diagnostics Company

November 12, 2012

BOSTON--(BUSINESS WIRE)--Bristol-Myers Squibb’s Investigational Hepatitis C Compounds Lambda and Daclatasvir Plus Ribavirin Achieved SVR12 in 93% of Genotype 1b Treatment-Naive Patients In Phase IIb Study

November 12, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. today announced that Neil K. Warma, President & CEO, will present at the Lazard Capital Markets 9th Annual Healthcare Conference on Wednesday, November 14 in New York City.

November 12, 2012

DALLAS--(BUSINESS WIRE)--Discount Dental Materials, Inc. (OTCBB: DDOO), announced today that it expects to file its quarterly report on Form 10-Q on November 14, 2012. This report will detail DDOO’s results of operations and financial position...

November 12, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Paris:ALCLS), the genome-engineering specialist, was honored to welcome Professor Yamanaka, this year’s Nobel laureate in medicine, for a meeting with the Group's teams at its Paris headquarters...

November 12, 2012

NASHVILLE, Tenn.--(BUSINESS WIRE)--Insight Genetics, Inc. today announced it has received two Small Business Innovation Research (SBIR) contracts from the National Cancer Institute (NCI) to continue its work developing diagnostic tests that...

November 12, 2012

NIJMEGEN, Netherlands--(BUSINESS WIRE)--The researchers in this article propose a neuro-anatomical model of neurofeedback, where neurofeedback results in falling asleep faster and better being able to maintain sleep.

November 12, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE: ENZ), a vertically integrated biosciences and clinical laboratory company, announced today that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be...

November 12, 2012

EAST LANSING, Mich.--(BUSINESS WIRE)--MichBio, the association for Michigan’s biosciences industry, welcomed approximately 300 bioscience professionals and service providers to its eighth annual Expo & Conference held November 7-8 at the...

November 12, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) to Present at the Credit Suisse 2012 Healthcare Conference on November 14, 2012

November 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Discovery Presents Preclinical Data on Highly Selective IRAK4 Inhibitors for the Treatment of Rheumatic Diseases

November 12, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--PATH’s Drug Development program announced today the completion of two phase 1 clinical studies for iOWH032—its investigational new drug to treat acute secretory diarrhea caused by diseases such as...

November 12, 2012

DENVER--(BUSINESS WIRE)--The AspirinWorks Test from Corgenix Medical Corporation has received approval from the SFDA to begin marketing the aspirin effect test in China.

November 12, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (OTCBB:ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-...

November 12, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Presents New Clinical Safety Data From the Pediatric Development Program for ZETONNA® at ACAAI Annual Meeting

November 12, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced new clinical trial results showing the subcutaneous (SC) formulation of Orencia® (abatacept) on a background of methotrexate (MTX) was similar to Humira® (...

November 12, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the atrial fibrillation drug market will experience dramatic growth over the next...

November 12, 2012

MILAN--(BUSINESS WIRE)--Sorin Group acquires Neurotech SA, developer of neurostimulation devices. Acquisition will accelerate the time to market Sorin’s neuromodulation therapies to treat Heart Failure.

November 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals announces Third Quarter 2012 Financial REsults and expects near-term milestones in autoimeune disease drug development programs.

November 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of...

November 12, 2012

NORCROSS, Ga.--(BUSINESS WIRE)--Galectin Therapeutics has reported new data at AASLD on its galectin inhibitor for the treatment of liver fibrosis. The data presented help to further explain the mechanism of action of GR-MD-02.

November 12, 2012

SAN DIEGO--(BUSINESS WIRE)--Cytori announced that a peer-reviewed case series using Cytori’s cell therapy to treat patients with complex cryptoglandular fistula has been published in the British Medical Journal: Case Reports.

November 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ensemble demonstrates Activity of Novel Small Molecule Interleukin-17 Antagonists in Multiple Models of Inflammation at the 2012 ACR Annual Meeting

November 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals Announces $7 million financing to support autoimmune disease drug development programs with near term milestones in lupus and psoriasis programs

November 12, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation is presenting at Bio-Europe 2012 the preeminent partnering conference serving the global biotechnology industry

November 12, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions will webcast "fireside chat" at Piper Jaffray's 24th Annual Healthcare Conference, 2:00PM Tuesday, November 27, 2012.

November 12, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Receives 2012 Zenith Award from American Association for Respiratory Care

November 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine and AstraZeneca Announce Genomic Profiling Collaboration

November 12, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that VWR International, LLC, a global distributor of laboratory supplies and services, will distribute Illumina’s qPCR portfolio including the Eco™ Real-Time PCR System and...

November 12, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced proof-of-principle data demonstrating that BCX4430 is efficacious and well tolerated in a preclinical disease model for evaluating...

November 12, 2012

PITTSBURGH--(BUSINESS WIRE)--A new study that looks at the synergy between ChemoFx® in vitro drug response marker results for non-platinum single agents alone and in combination with carboplatin was presented at the International Gynecologic...

November 12, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced third quarter results for the period ended September 30, 2012. For the three months ended September 30, 2012, the Company reported...

November 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that CEO Frank Reynolds...

November 12, 2012

OSLO, Norway--(BUSINESS WIRE)--Vaccibody receives 2 million Euros to develop novel missing link DNA vaccine against precancerous lesions of the cervix.

November 12, 2012

DÜSSELDORF, Germany--(BUSINESS WIRE)--Welch Allyn will showcase solutions that can help cure some of the healthcare industry’s largest afflictions this week at the 2012 Medica International Trade Fair and Congress in Düsseldorf, Germany.

November 12, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Fingerprint Cards (STO:FINGB)(FPC) has completed integration of FPC’s algorithm and swipe sensor into the embedded Secure Element from Infineon Technologies. The primary solution will be plug &...

November 12, 2012

MOSCOW--(BUSINESS WIRE)--Fabrice Egros was appointed as COO, Pharmaceutical Director and board member of NovaMedica, a novel Russian pharmaceutical company, which was established within the frameworks of the joint project between RUSNANO and the...

November 12, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the results from its LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 versus gemcitabine in metastatic pancreatic cancer. There was no...

November 11, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--SCYNEXIS announced results of a P2a study of SCY-635 with Peg-IFN/RBV for treatment of HCV that showed it could play an important role in the reversal of immune exhaustion in patients with HCV.

November 11, 2012

BOSTON--(BUSINESS WIRE)--Investigational Hepatitis C Dual DAA Regimen of Daclatasvir and Asunaprevir Achieved SVR12 in 78% of Difficult-to-Treat Genotype 1b Prior Null Responders In Expanded Phase II Study

November 11, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of early interim results from a single-arm, open-label Phase IB study that has so far enrolled 132...

November 10, 2012

WASHINGTON--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that results from the ADACTA study will be presented on November 11 during an oral presentation at the 2012 American College of...

November 10, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim’s interferon-free all-oral hepatitis C treatment shows up to 85% viral cure in Phase IIb study including patients with advanced liver disease